🔴 Moleculin Biotech is trading 7.21% down today with no clear company-specific catalyst

Moleculin Biotech is trading at $0.77, down 7.21%, with no clear company-specific catalyst explaining the decline.

• Reversed the September 10, 2026 close of $0.83 and prior session’s 8.48% gain.
• H.C. Wainwright conference presentation became available at 7:00 a.m. ET, with no new major corporate event or stated connection to the move.
• Broader markets are higher, so macro sentiment does not explain the weakness.